Don’t miss the latest developments in business and finance.

Glenmark Pharmaceuticals standalone net profit declines 47.80% in the June 2017 quarter

Image
Capital Market
Last Updated : Jul 28 2017 | 2:48 PM IST

Sales decline 6.00% to Rs 1510.93 crore

Net profit of Glenmark Pharmaceuticals declined 47.80% to Rs 270.84 crore in the quarter ended June 2017 as against Rs 518.81 crore during the previous quarter ended June 2016. Sales declined 6.00% to Rs 1510.93 crore in the quarter ended June 2017 as against Rs 1607.35 crore during the previous quarter ended June 2016. ParticularsQuarter EndedJun. 2017Jun. 2016% Var.Sales1510.931607.35 -6 OPM %23.3637.39 -PBDT349.79687.80 -49 PBT319.85662.32 -52 NP270.84518.81 -48

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

More From This Section

First Published: Jul 28 2017 | 2:24 PM IST

Next Story